Sexuality is an important component of emotional and physical intimacy that men and women experience through their lives. Male erectile dysfunction (ED) and female sexual dysfunction increase with age. About a third of the elderly population has at least one complaint with their sexual function. However, about 60% of the elderly population expresses their interest for maintaining sexual activity. Although aging and functional decline may affect sexual function, when sexual dysfunction is diagnosed, physicians should rule out disease or side effects of medications. Common disorders related to sexual dysfunction include cardiovascular disease, diabetes, lower urinary tract symptoms and depression. Early control of cardiovascular risk factors may improve endothelial function and reduce the occurrence of ED. Treating those disorders or modifying lifestyle-related risk factors (eg obesity) may help prevent sexual dysfunction in the elderly. Sexuality is important for older adults, but interest in discussing aspects of sexual life is variable. Physicians should give their patient's opportunity to voice their concerns with sexual function and offer them alternatives for evaluation and treatment.
Introduction
Sexuality is one aspect of the emotional and physical intimacy that men and women experience through their lives. In adulthood, the closest intimacy is accomplished by physical and sexual relationships. Sexual intimacy is desired by older adults when there is a partner and a health status that allows sexual relationships. 1, 2 Older individuals desire to love and enjoy sexual activity in relation to personal circumstances, and when health status allows them to experience close relations, most often within marriage. [3] [4] [5] Normal changes occur in the phases of sexual cycle with aging, mainly men needing more time and stimulation to achieve a complete erection. 6 The importance of sex in maintaining a good relationship in a couple persists with advancing age, but is affected by sexual dysfunction (SD). Various medical problems can be approached by primarycare providers of older patients with SD with focus on modifiable risk factors, to contribute to improving sexual function with aging.
Prevalence
There is limited knowledge among primary-care practitioners with regard to the concerns and needs of elderly men and women, in particular with regard to sexuality. Early surveys on human sexuality included few elderly subjects, but recent studies have included a greater number of older men and women, across various ethnic groups. [7] [8] [9] [10] [11] [12] [13] Various studies showed that 10% of men over 35 y reported erectile dysfunction (ED) and 25% occasional ED. However, after the age of 70 y, this percentage climbs to 75%. 8, 14, 15 Data collected between 2001 and 2002 in 27 000 men and women aged 40-80 y, across 29 countries, revealed that 28% of men and 39% of women had at least one complaint with sexual function. Nearly one-half of the men sampled between 70 and 80 y reported having intercourse during the year previous to the interview, as opposed to only 21% of the women. Only 17% men and 23% women in the sample said 'older people no longer want sex'. And 68% men and 60% women were 'in favor' of older people using medical treatments to help enjoy sexual activity. 16 The prevalence of ED mainly increased with age. Lack of interest in sex and inability to reach orgasm are frequent among women, but not so dependent on aging. When clinical patients in contrast to community-based women are screened, the prevalence of female sexual dysfunction (FSD) is higher and there is greater association with age.
SD and disease
Both acute and chronic disease mediate a decline in sexual function and cause a decreased interest in sex. Disease affects mobility and tolerance to physical activity, reducing sexual desire. Body image and perceived attractiveness are modified by aging and disease with reduced desire for relationships.
Cardiovascular disease is a leading cause of morbidity in the elderly and frequently associated with SD. Advanced age in itself constitutes a risk factor for vascular dysfunction even when other known risk factors are absent. 19, 20 Intact neurologic and vascular systems are necessary for normal erections and for normal arousal in women. The release of nitric oxide (NO) from both endothelial cells and neurons results in vasodilatation causing penile engorgement and erection. Risk factors for cardiovascular disease may cause erectile failure at early stages mediated by endothelial dysfunction. 21, 22 Men with penile arterial insufficiency and ED without known coronary artery disease (CAD) investigated for vascular risk factors had a positive correlation between the severity of ED and Creactive protein (CRP) even when adjusted for age. 23 Body mass index (BMI) and abnormal lipid profile measured in middle-aged men were predictors of ED 25 y later. 24 Obesity is associated with elevated levels of proinflammatory cytokines and CRP resulting in endothelial dysfunction 25 and hypogonadism. 26 Lifestyle changes to reduce weight resulted in improved sexual function in one-third of obese men under 55 y, and also resulted in reduced CRP and interleukin 6. 27 A health screening study of volunteers showed no association between BMI and ED, but the population studied was younger and mean BMI lower than in other reports. 28 Investigating cardiovascular risk factors in men with ED reveals 15% with abnormal fasting glucose and another 12% who had normal fasting glucose but abnormal glucose tolerance tests. 29 ED is common in diabetic men, present in about 75% of diabetic men over 60 y and older. Diabetic men with ED are also at high risk for coronary heart disease and should be candidates for stress test. 30 The prevalence of SD is also high in diabetic women and more prevalent with age and low-grade education. 31 High total cholesterol and LDL cholesterol in men older than 40 were associated with ED in contrast to younger men and controls suggest that hyperlipidemia explains, in part, ED with age. 32 Hypertension causes endothelial dysfunction, and is associated with ED. 22 Blood pressure adjustment and adequate control of other risk factors improves erectile function, unless medications adversely affect it. Men with ED have a twofold increased risk for acute myocardial infarction (AMI) after adjusting for age at onset of ED and known risk factors. The risk increases even more with aging and men 55 y and older have a four-fold increased risk of AMI. 33 Arthritis is a major cause of disability mainly for older women, but older men may also complain of pain and stiffness interfering with sexual activity. 34 Most common psychologic disorders in older men with SD includes alcohol abuse and depression. 35 Both estrogen and testosterone production universally decline in women and in a smaller proportion in men with age. Low testosterone results in decreased libido in both men and women, and may affect erectile function when severely lowered in men. Systemic disease affects sexual function in men by directly inhibiting testosterone synthesis in the testes or by modulating the release of gonadotropins by the pituitary as reviewed above. Men with renal failure have low testosterone blood level that may be restored by erythropoietin and by renal transplantation. Liver failure in subjects with cirrhosis causes hypogonadism, gynecomastia and decreased libido. Advanced pulmonary disease results in ED and low levels of testosterone. 20 Lower urinary tract symptoms (LUTS) are common in both older men and women and frequently associated with SD. 36 They may represent specific age-related pathology, be it a manifestation of a systemic illness or a resultant of medications used for comorbid conditions. This way illness mediates decline in sexual function by the adverse effect of prescribed medications.
Effect of medications on sexual function
All systems have limited homeostatic reserve with aging, resulting in decreased clearance and enhanced toxicity of many drugs. Undesired effects of medications are for these reasons quite prevalent in the elderly. The odds of being polymedicated also increase with advanced age and common medication interactions tend to occur more often in the older old. Patients may believe any new symptoms are a result of old age and may not report the occurrence to their physician. Unless there is an inquiry about common side effects of any given medication, they may be overlooked. New symptoms such as decreased libido, lack of lubrication or ED may result from drugs are being presented. Older subjects may not report these symptoms unless the practitioner gives them an opportunity by asking few questions about their sexual health.
Medications that affect the nervous system will have some effect on sexual function. Selective serotonin reuptake inhibitors are commonly associated with SD in men and women, mainly decreased libido, whereas bupropion, mirtazepine and nefazodone less frequently cause ED and FSD. 37, 38 Tricyclic antidepressants have less negative effect on sexual desire, but may cause anticholinergic side effects resulting in LUTS and associated SD. Sildenafil has been successfully used when SD was caused by antidepressants. 39 Neuroleptic medications are dopamine antagonists and increase prolactin, resulting in testosterone antagonism and decreased libido.
Men with hypertension may have ED due to vascular insufficiency or it may be associated with end-organ vascular disease, such as claudication or CAD. Use of antihypertensive drugs may also result in ED, which may be the result of blood pressure reduction itself and not a side effect of the medication. 40 Clonidine may cause ED in 20-30% of men. Other centrally acting sympatholythic agents such as methyldopa are used less frequently and may cause impotence more often. Beta-blockers may cause SD depending on the degree of beta blockade. 41 Propranolol at high dose often causes ED, but lower doses of metoprolol, atenolol and carvedilol cause ED only as much as other antihypertensives. 42 Timolol eye drops have been reported to cause ED and may easily be overlooked as a causative agent.
Angiotensin-converting enzyme inhibitors and calcium channel blockers have a safer profile and may be alternative medications for subjects troubled by SD caused by other antihypertensives. Lipid-lowering agents (fibrates, niacin) have been associated with ED and the mechanism is not clear, but probably they affect the production of sex hormones. 43 Older people are more sensitive to side effects of medications, in part due to underlying comorbid disease. Medications that interfere with normal sexual functioning are necessary at least for periods of time during the management of intercurrent illness or long term in the control of chronic disease. When possible, medications that cause symptomatic SD should be replaced in order to improve SD. Agents that cause a side effect may be easily identified if introduced one at a time and a causative relation with symptoms will be proven by restoring function after withdrawal. At other times, it is necessary to treat common side effects such as vaginal dryness or ED specifically, while the offending medication is continued.
SD with age in men
The Massachusetts Male Aging Study (MMAS) has studied ED and male hormones in a random sample of men 40-70 y interviewed at home since 1987. The primary independent variable of MMAS is age and the primary goal of the study is the individual's variation of hormones over time. According to MMAS, the probability of complete ED triples from 5% in 40 y old men to 15% in 70 y old men. 13, 44 Voluntary health examinations of men between 20 and 80 y revealed 32% had some ED when screened using IIEF-5. ED was present in 26% (20-30 y), 29% (31-50 y) and 37.5% (51-60 y), and increased to 71.2% in those between 71 and 80 y. 28 Cardiovascular risk factors and vascular disease result in endothelial dysfunction and early development of erectile failure. Smoking, obesity, hypertension, diabetes and dyslipidemias contribute to ED in elderly men. 20, 23, 45 Although vascular comorbidities are associated with ED, a study using neural computational networks identified SHIM scores representing moderate ED correlated with age, total testosterone and a depression scale. 46 Testosterone declines with age in men at a rate of 1-2% a year. Free testosterone levels are reduced from 3% in the fifth decade and up to 30% in the 7th decade. Sex hormone binding globulin that normally binds 60% of total testosterone may bind up to 75% in older men, and only 1-2% of testosterone is free, while the remaining is bound to albumin. A smaller amount of free testosterone becomes available to enter the cell at a tissue level. 47, 48 In contrast to menopausal women, there is no remarkable raise in luteinizing hormone (LH) in older men, but levels are higher than in younger men. This suggests secondary hypogonadism, but testicular failure has been demonstrated by decreased response to LH and gonadotropin-releasing hormone in older men. 49, 50 Total testosterone and bioavailable testosterone levels should be measured in symptomatic men.
LUTS carry an increased risk of SD independent of age. 10, 51 The relative risk of ED in subjects with LUTS is 1.8-7.5. 52 Benign prostatic hypertrophy (BPH) is the most common cause of LUTS in older men. Severity increases with age causing increased urgency, frequency, poor sleep quality, anxiety and fatigue. Sexual activity including intercourse is negatively affected by LUTS and may be improved by treatment for bladder obstructive symptoms with alpha-blockers. 53 Prostate cancer (PC) incidence increases with age and either surgical or nonsurgical therapies may cause SD. Although 24% reported low desire and 49.5% 'very poor' response of sexual function, only 24% of men 1 year after treatment for early stage PC made any attempt to improve sexual functioning. In those with sexual desire and poor sexual functioning, quality of life was affected by impaired erectile function. 54 The prevalence of SD is higher when investigated by using a validated questionnaire as opposed to asking one single question with regard to erectile function. One single question with regard to ED in the MMAS correlated well with two commonly used validated questionnaires to determine ED in population surveys. [55] [56] [57] Other instruments have been developed to be self-administered in the context of quality of life and ED. 58, 59 The use of validated instruments in clinical work has been suggested in order to improve the diagnostic rate of ED and create an increased opportunity for therapy, but just asking one general question as opposed to none is the first need in clinical practice.
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SD with age in women
Women may experience occasional or intermittent difficulties in relation with sexual activity, decreased desire and inability to reach orgasm or pain during intercourse. When these symptoms become persistent or quite frequent, it can be considered as an SD and may have an underlying cause. 60 ,61 FSD affects 30-50% of women and correlates with age, education, physical and emotional health. 17, 31, 62 Older women screened for sexual concerns during a routine gynecological visit reported a similar number of concerns as younger women. Women of any age reported decreased sexual desire, sexual aversion and desires different from their partners, unmet sexual needs and having had or considering having an affair. However, older women focused also on different aspects of their relations such as concern about the sexual health of their partner. Older women reported that their physicians do not inquire about their sexual health on general healthcare visits and that they will be willing to discuss their needs if the physician raised the topic. 63 FSD is also related to their partner's function: when erectile failure of male partner has improved, women's desire, sexual arousal, orgasm and satisfaction improves. 64 Female partners of men treated with sildenafil experience high levels of treatment satisfaction, but one in five were concerned about adverse events. 65 Depression is frequently associated with FSD (over 70%), which may be worse during treatment. Selection of medications should take into account SD and patient desire to improve sexual activity. 66 Healthy women before and after menopause, who had either normal menses or hormone replacement therapy but low libido, had lower levels of androgens, including total testosterone, free testosterone, and dehydroepiandrosterone sulfate when compared with women with normal libido. 67 
Conclusion
There is decline in sexual function with age that may affect the quality of life. Disease and functional decline account for decreased interest in sexual activity in the very old. Longitudinal population surveys ongoing at this time will probably improve our understanding of sexuality in the older old. Risk factors other than age are strongly associated with ED and FSD. Subjects with SD should be screened for cardiovascular risk factors, risk of coronary disease and LUTS. Control of cardiovascular risk factors may improve endothelial function and ED. Patients' early awareness of the relation between cardiovascular risk factors and ED will encourage patients to adhere to better control and lifestyle changes. LUTS is a common problem in elderly men and women associated with SD that may improve with therapy.
Sexuality is important for older adults, but interest in discussing aspects of sexual life is variable. Physicians should give their patients' an opportunity to voice their concerns with sexual function and offer them alternatives for evaluation and treatment.
